Detalhe da pesquisa
1.
Rift Valley fever virus: an unrecognized emerging threat?
Hum Vaccin
; 6(7): 597-601, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20421731
2.
A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.
Sci Rep
; 4: 3775, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24441019
3.
Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles.
J Virol Methods
; 169(2): 259-68, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20655330
4.
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.
Virology
; 397(1): 187-98, 2010 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19932911
5.
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Vaccine
; 25(15): 2800-10, 2007 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17240489
6.
Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Infect Immun
; 74(11): 6339-47, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16966409